Aspira Women?s Health Inc. announced it has named Michelle Snider as Senior Vice President, Commercial Strategy and Operations. Ms. Snider has spent her 20+ year career in women?s healthcare and diagnostics. She joins Aspira from Sema4 Genomics where she served as Vice President of Market Enablement/Sales Strategy during the company?s extraordinary growth.

In this role, she was responsible for women?s health commercial strategy and oversaw its financial and operational performance. Prior to Sema4, Ms. Snider was Vice President of Sales for Sonic Reference Laboratory Inc., where she led commercial development through the successful launch and growth of esoteric testing. Ms. Snider returns to the company having been part of the commercial leadership team during the development and launch of Ova1 after joining Aspira from Myriad.